The peroxidaee action of myoglobin and haemoglobin has been recognised for several decades [l]. The interaction of MetMb with peroxides involves the formation of a ferry1 (iron IV-0x0) species and a protein radical [ We can conclude that a novel hydroxamate drug, NBMH, can protect against MetMb-and ferrylMb radical-induced lipid peroxidation of LDL. Haem is damaged in ferrylMb in the presence of LDL which can be prevented by the action of NBMH.
The peroxidaee action of myoglobin and haemoglobin has been recognised for several decades [l] . The interaction of MetMb with peroxides involves the formation of a ferry1 (iron IV-0x0) species and a protein radical [2] . It is not clear which of these species is responsible €or oxidative damage to biological substrates. It has been proposed that the radical on the surface of the haem protein is located on tyrosine-103, in equine MetMb [3, 4] . This protein radical has been characterised by applying epr, both stop-flow and spin-trapping (DMPO). The DMPO-adduct decays rapidly being reduced to approximately 10% of its initial intensity after 10 minutes. Our recent studies [5] We can conclude that a novel hydroxamate drug, NBMH, can protect against MetMb-and ferrylMb radical-induced lipid peroxidation of LDL. Haem is damaged in ferrylMb in the presence of LDL which can be prevented by the action of NBMH.
In this work we have applied low

